Anxuyuan Biotechnology (Shenzhen) Company Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Anxuyuan Biotechnology (Shenzhen) Company Limited - overview
Established
2016
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Based in Shenzhen, China, and established in 2016, Anxuyuan Biotechnology (Shenzhen) Company Limited operates as a medical device developer that provides sequencing and diagnostic systems, biochips, and detection reagents. It has R&D centers in the United States, China, and Europe. The company has developed a microfluidic Bio-CMOS platform capable of high-throughput sequencing and molecular diagnostics that make it possible to manufacture handheld devices for bedside diagnostics to fully automate instruments for laboratories and hospitals. As of 2022, the company completed three rounds of financing.
The company provides sequencing and diagnostic systems, as well as biochips and detection reagents. They can be applied in early cancer screening and detection, rapid pathogen detection and drug development. The company also provides customized services for chemical synthesis reagents, multiple pathogen detection kits and multiple sample nucleic acid extraction kits.
Current Investors
5Y Capital, MSA Capital, Kaitai Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic Equipment
Website
www.axbio.cn
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.